Pamela Esposito, Director at Kymera Therapeutics, Inc. (KYMR), sold 4,400 shares at $87.06 ($384K) on 2026-02-20, disclosed to the SEC on 2026-02-20.
Open-market sale of $384k KYMR by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $87.06 | 1,900 | $165K | 43.1% |
| 2 | $87.06 | 1,900 | $165K | 43.1% |
| 3 | $88.10 | 600 | $53K | 13.8% |
| Total | $87.20 avg | 4,400 | $384K | 100% |
| Filing → |
| KYMR | SELL | 2025-12-17 | $4.4M | — | Filing → |
| KYMR | SELL | 2025-06-03 | $245K | — | Filing → |
| KYMR | SELL | 2024-12-02 | $123K | — | Filing → |